NDA 218024 describes SUNITINIB MALATE, which is a drug marketed by
Dr Reddys,
Eugia Pharma,
Mylan,
Natco Pharma,
Sun Pharm,
Teva Pharms Usa, and
Wanbang Biopharms, and is included in seven NDAs. It is available from
eight suppliers. Additional details are available on the
SUNITINIB MALATE profile page.
The generic ingredient in SUNITINIB MALATE is
sunitinib malate. There are eight
drug master file entries for this compound. Ten
suppliers are listed for this compound. Additional details are available on the
sunitinib malate profile page.